/ Journal of the American Society of Nephrology
Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Refardt J, Imber C, Nobbenhuis R, Sailer CO, Haslbauer A, Monnerat S, Bathelt C, Vogt DR, Berres M, Winzeler B, Bridenbaugh SA, Christ-Crain M.
J Am Soc Nephrol. 2022 Nov 17:ASN.2022050623. doi: 10.1681/ASN.2022050623.
Online ahead of print.